According to Race Oncology's latest financial reports the company's current EPS (TTM) is -$0.06897. In 2023 the company made an earnings per share (EPS) of -$0.06897 an increase over its 2022 EPS that were of -$0.08458.
Year | EPS | Change |
---|---|---|
2023 | -$0.06897 | -18.46% |
2022 | -$0.08458 | 37.74% |
2021 | -$0.06141 | 47% |
2020 | -$0.04177 | -23.41% |
2019 | -$0.05454 | -53.58% |
2018 | -$0.12 | 14.62% |
2017 | -$0.10 | 190.27% |
2016 | -$0.03532 | |
2015 | N/A |